Metabolism at Corcept Therapeutics

Redwood City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

MD, PharmD, or PhD with experience in Internal Medicine, Metabolic disease (e.g. MASH, Type 2 diabetes) or Endocrinology preferable
0-3 years of relevant clinical development experience
Industry experience and experience in medical monitoring
Demonstrate strong clinical and scientific knowledge
Are an excellent communicator with proven leadership skills and the ability to interact in a cross functional environment
Feel comfortable in a fast-paced and nimble small company environment and able to adjust workload based upon changing priorities

Responsibilities

Act as a clinical scientist and clinical subject matter expert for both Company team members and for external contacts related to the assigned therapeutic programs
Act to provide medical oversight and safety monitoring for ongoing clinical trials including participation in SAE reporting and serving on the safety committee
Design, develop and implement clinical studies for the applicable drug candidate, from Phase 1 through Phase 4
Develop and give internal and external presentations as a subject matter expert for the therapeutic area
Develop and participate in the writing and review of protocols, investigator brochures, study reports and other clinical and regulatory documents
Establish and approve scientific methods for design and implementation of applicable clinical protocols, data collection systems and final reports
Interact with principal investigators and opinion leaders to facilitate clinical trials research
Participate in appropriate regulatory discussion and activities, including the filing of INDs, CTXs and NDA/MAAs, throughout the development cycle
Participate in clinical study report conceptualization, development and writing for global regulatory submissions
Participate in the development and review of publications
Participate in the management of human resources in a matrixed environment – recruitment, performance management, succession planning, talent management, etc
Play a key role in the analysis, interpretation and delivery of high quality clinical data
Prepare and monitor budgets in collaboration with clinical operations and R&D finance
Provide scientific oversight for Company operational staff, contract research organizations (CROs), and clinical trial sites in all areas related to the therapeutic programs
Provide training and ongoing input to all members of the clinical team on medical and scientific issues related to the therapeutic field in question
Serve as a liaison to the commercial team on medical issues
Work closely and collaboratively with other functions, e.g. clinical operations, safety, biometrics, regulatory, medical writing, medical affairs and commercial

Skills

Clinical Development

Endocrinology

Metabolism

Clinical Trials

Safety Monitoring

SAE Reporting

Protocol Writing

Investigator Brochures

Regulatory Documents

Cortisol Modulation

Corcept Therapeutics

Develops cortisol modulators for medical conditions

About Corcept Therapeutics

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing various health issues. Their main product, Korlym, is used to treat Cushing's syndrome, a condition caused by too much cortisol. Korlym was approved by the FDA in 2012 and is the first medication specifically for this disorder. Corcept stands out from competitors by having a strong emphasis on research and development, having discovered over 1,000 unique cortisol modulators. The company aims to expand its range of treatments while also providing educational resources to healthcare professionals and patients to improve understanding and care for cortisol-related conditions.

Menlo Park, CaliforniaHeadquarters

1998Year Founded

$39.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Remote Work Options

Flexible Work Hours

Risks

Teva's antitrust lawsuit could lead to legal expenses and market share loss.

Heavy reliance on Korlym makes Corcept vulnerable to market fluctuations.

Recent investments may pressure Corcept for short-term financial performance, impacting R&D.

Differentiation

Corcept specializes in cortisol modulation, a niche with few direct competitors.

Korlym is the first FDA-approved treatment for Cushing's syndrome, a significant market advantage.

Corcept's extensive R&D has led to the discovery of over 1,000 selective cortisol modulators.

Upsides

Increased interest in cortisol therapies for mental health boosts Corcept's R&D prospects.

Advancements in drug delivery systems could enhance Corcept's product efficacy.

The FDA's fast-track designation supports Corcept's innovative cortisol-related treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free